Table 1 Top 20 enriched GO terms for each comparison.
Antigen-only | Tolerant/2 nM | Desensitized/5 nM | |
|---|---|---|---|
Term (adjusted P-value | mean log2Fold-change) | Term (adjusted P-value | mean log2Fold-change) | Term (adjusted P-value | mean log2Fold-change) | |
Immune general | Negative regulation of immune system process (3.75e-13 |− 1.60) | Negative regulation of immune system process (0.002 |− 1.88) Regulation of hemopoiesis (0.003 |− 1.04) | Negative regulation of immune system process (0.002 |− 0.59) Defense response to Gram-positive bacterium (0.008 |− 1.42) Chronic inflammatory response (0.01 |− 1.12) Regulation of hemopoiesis (0.003 |− 0.25) |
Immune cells processes | Regulation of leukocyte differentiation (2.61e − 13 |− 1.48) Lymphocyte differentiation (3.74e − 13 |− 1.29) Leukocyte cell–cell adhesion (2.07e − 12 |− 1.48) Regulation of cell–cell adhesion (3.70e − 12 |− 1.58) Regulation of T cell activation (9.62e − 12 |− 1.43) Positive regulation of cell activation (4.26e − 11 |− 1.52) Negative regulation of leukocyte activation (2.42e − 10 |− 1.46) Leukocyte proliferation (4.64e − 09 |− 1.34) Regulation of leukocyte proliferation (6.29e − 09 |− 1.31) Alpha–beta T cell activation (6.87e − 09 |− 1.40) Myeloid leukocyte activation (6.93e − 09 |− 1.41) Regulation of lymphocyte proliferation (6.93e − 09 |− 1.43) Cell chemotaxis (6.93e − 09 |− 1.65) Lymphocyte proliferation (1.59e − 08 |− 1.42) Immune receptor activity (2.02e − 08 |− 1.50) | Glucocorticoid receptor binding (3.70e − 05 |− 1.67) Regulation of cell–cell adhesion (0.002 |− 0.89) Regulation of T cell activation (0.002 |− 0.34) Leukocyte cell –cell adhesion (0.002 |− 0.41) Alpha–beta T cell activation (0.005 |− 0.72) | Regulation of lymphocyte proliferation (0.0008 |− 0.46) Regulation of mononuclear cell proliferation (0.0008 |− 0.46) Positive regulation of leukocyte activation (0.003 |− 0.77) Positive regulation of cell activation (0.003 |− 0.77) Lymphocyte proliferation (0.003 |− 0.46) Mononuclear cell proliferation (0.003 |− 0.46) Leukocyte cell–cell adhesion (0.003 |− 0.70) Regulation of leukocyte cell–cell adhesion (0.009 |− 0.39) Regulation of T cell activation (0.01 |− 0.65) Alpha–beta T cell activation (0.01 |− 0.80) |
Cytokines related | Positive regulation of cytokine production (9.44e − 14 |− 1.53) Negative regulation of cytokine production (2.75e − 09 |− 1.56) Cytokine binding (3.40e − 08 |− 1.52) | Cytokine binding (2.58e − 06 |− 1.49) Cytokine receptor activity (1.04e − 05 |− 0.51) C–C chemokine receptor activity (0.002 |− 0.75) G protein-coupled chemoattractant receptor activity (0.002 |− 0.75) Chemokine receptor activity (0.002 |− 0.75) Positive regulation of cytokine production (0.002 |− 1.57) Negative regulation of cytokine production (0.003 |− 2.37) | Secretory granule (0.0002 |− 1.49) Regulation of interleukin-12 production (0.01 |− 1.45) Interleukin-12 production (0.01 |− 1.45) |
Cellular metabolism & signaling | Negative regulation of phosphorylation (0.002 |− 1.08) Response to unfolded protein (0.002 |− 0.66) Negative regulation of transferase activity (0.002 |− 1.14) Negative regulation of MAPK cascade (0.002 |− 0.98) Positive regulation of cellular catabolic process (0.002 |− 0.99) DNA-binding transcription factor binding (0.004 |− 1.34) | Negative regulation of cysteine − type endopeptidase activity (0.008 |− 1.80) Negative regulation of hydrolase activity (0.009 |− 1.67) Positive regulation of tyrosine phosphorylation of STAT protein (0.01 | 0.74) | |
Other | Regulation of vasculature development (7.60e − 09 |− 1.83) |